
94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Pharmacol.
Sec. Pharmacology of Infectious Diseases
Volume 16 - 2025 | doi: 10.3389/fphar.2025.1555542
This article is part of the Research Topic Design and Synthesis of Natural Antibacterial Derivatives View all articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Multidrug-resistant bacterial pathogen Pseudomonas aeruginosa has emerged as a significant global health challenge, underscoring the urgent need to identify and develop alternative therapeutic agents including plant natural products. In this study, the extract from Clidemia hirta plant extract was analyzed for antibacterial properties against P. aeruginosa and component composition. Material and Methods: The plant extract was obtained from leaves of C. hirta and its antibacterial activity against P. aeruginosa was determined in Kirby-Bauer disc diffusion assay. In this assay, the activity of the extract was tested at two different concentrations of 50 and 100 μg/mL. The minimum inhibitory concentration (MIC) of the extract against P. aeruginosa was used with its MIC values against Vero cells to determine the selectivity index. GC-MS determined the phytochemical composition of the plant extract. The property of different extract components to bind the target receptor Penicillin Binding Protein 2a (7KIS) was assessed in silico studies including docking and molecular dynamics (MD) analyses. In these analyses, the stability and interaction dynamics of the Penicillin Binding Protein 2a (7KIS) protein complexed with selected extract components. Results: The plant extracts had antibacterial activity against P. aeruginosa, with inhibition zones measuring 13 mm and 19 mm for 50 and 100 μg/mL concentrations, respectively. The MIC of the plant extract was determined to be 20 μg/mL, while its selectivity index was 4.54, indicating its antibiotic potential. One extract component, 2, 4-di-tert-butylphenol compound holds a binding affinity of -6.2 kcal/mol in molecular docking studies. MD simulations revealed stable binding interactions between the 7KIS protein and the tested ligands, characterized by reduced atomic fluctuations and energetically favorable binding profiles. Conclusion: This study showed that C. hirta extract has a robust antibacterial potential against P. aeruginosa. Furthermore, GC-MS profiling molecular docking, and dynamic simulation data showed that such antibacterial potential might be attributed to its one component, 2, 4-di-tert-butylphenol. Further, in vivo and in vitro studies are needed to show the applicability of bioactive compounds from C. hirta in combating resistant bacterial pathogens.
Keywords: Clidemia hirta, Pseudomonas aeruginosa, Antibacterial activity, pathogenicity, Penicillium Binding Protein
Received: 04 Jan 2025; Accepted: 17 Feb 2025.
Copyright: © 2025 Murugesan, Palanivel, Ramesh, Ganesh, Michael, Bandhumy Lingam and Sivaraman. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Rathish Kumar Sivaraman, Sri Ramakrishna College of Arts and Science (SRCAS), Coimbatore, 641006, Kerala, India
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.